XTX Topco’s GoodRx Holdings GDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$430K Buy
219,408
+152,070
+226% +$357K 0.01% 2177
2025
Q4
$182K Buy
+67,338
New +$221K ﹤0.01% 2438
2025
Q3
Sell
-272,273
Closed -$1.36M 2807
2025
Q2
$1.36M Buy
272,273
+200,852
+281% +$872K 0.06% 503
2025
Q1
$315K Buy
+71,421
New +$335K 0.02% 1366
2024
Q3
Sell
-29,560
Closed -$231K 2259
2024
Q2
$231K Buy
29,560
+8,801
+42% +$65.2K 0.02% 1137
2024
Q1
$147K Buy
+20,759
New +$137K 0.02% 1265
2023
Q2
Sell
-20,675
Closed -$129K 1546
2023
Q1
$129K Sell
20,675
-93,163
-82% -$519K 0.03% 1051
2022
Q4
$530K Buy
113,838
+41,511
+57% +$204K 0.11% 273
2022
Q3
$338K Buy
+72,327
New +$456K 0.08% 428
2022
Q2
Sell
-12,138
Closed -$235K 941
2022
Q1
$235K Buy
+12,138
New +$278K 0.1% 359
2021
Q4
Sell
-4,930
Closed -$202K 798
2021
Q3
$202K Buy
+4,930
New +$179K 0.07% 505
2021
Q2
Sell
-5,747
Closed -$224K 905
2021
Q1
$224K Buy
+5,747
New +$258K 0.11% 441

Other funds holding GDRX

XTX Topco's GDRX Position: Q1 2026 in Review

XTX Topco increased its GoodRx Holdings (GDRX) stake by 226% in Q1 2026, buying an estimated $357K and bringing the position to 219,408 shares worth $430K. The position accounts for 0.01% of the portfolio, ranked #2177.

XTX Topco first reported a position in GDRX in Q1 2021 and has held it in 12 quarters since. The position peaked at $1.36M in Q2 2025. 174 funds tracked by Wall St. Rank hold GDRX as of Q1 2026.

  • XTX Topco held 219,408 shares of GoodRx Holdings worth $430K as of Q1 2026.
  • XTX Topco bought 152,070 GoodRx Holdings shares in Q1 2026, an estimated $357K.
  • GoodRx Holdings made up 0.01% of XTX Topco's portfolio in Q1 2026, its #2177 holding.
  • XTX Topco first reported a position in GoodRx Holdings in Q1 2021 and has held it in 12 quarters since.
  • XTX Topco's GoodRx Holdings position peaked at $1.36M in Q2 2025.
  • 174 funds tracked by Wall St. Rank held GoodRx Holdings as of Q1 2026.

Based on XTX Topco's 13F filing for Q1 2026, filed 15 May 2026.